In conclusion, these data indicated that deletion of intestinal Slc16a1 in male mice significantly improves glucose homeostasis but did not affect diet-induced obesity, metabolic rate, and most of the blood lipid parameters. This evidence concerns the gene SLC16A1 and obesity disorder.